Ignite Creation Date:
2024-05-06 @ 3:33 AM
Last Modification Date:
2024-10-26 @ 11:35 AM
Study NCT ID:
NCT02318329
Status:
COMPLETED
Last Update Posted:
2024-06-04
First Post:
2014-11-25
Brief Title:
Open-Label Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors
Sponsor:
Five Prime Therapeutics Inc
Organization:
Five Prime Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Transitional Cell Carcinoma of the Bladder |
| Advanced Solid Tumors |
| Gastric Cancer |
Keywords:
| Name | View |
|---|---|
| FGFR2b FGFR2 FGFR bladder neoplasms esophageal cancer | View |